Home LiteratureArticle Details
PMID: 16700628 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

High guanine and cytosine content increases mRNA levels in mammalian cells.

PLoS biology ·Vol. 4 ·No. 6 ·2006-06-00 ·Pages e180

Kudla G, Lipinski L, Caffin F, Helwak A, Zylicz M

Abstract

Mammalian genes are highly heterogeneous with respect to their nucleotide composition, but the functional consequences of this heterogeneity are not clear. In the previous studies, weak positive or negative correlations have been found between the silent-site guanine and cytosine (GC) content and expression of mammalian genes. However, previous studies disregarded differences in the genomic context of genes, which could potentially obscure any correlation between GC content and expression. In the present work, we directly compared the expression of GC-rich and GC-poor genes placed in the context of identical promoters and UTR sequences. We performed transient and stable transfections of mammalian cells with GC-rich and GC-poor versions of Hsp70, green fluorescent protein, and IL2 genes. The GC-rich genes were expressed several-fold to over a 100-fold more efficiently than their GC-poor counterparts. This effect was not due to different translation rates of GC-rich and GC-poor mRNA. On the contrary, the efficient expression of GC-rich genes resulted from their increased steady-state mRNA levels. mRNA degradation rates were not correlated with GC content, suggesting that efficient transcription or mRNA processing is responsible for the high expression of GC-rich genes. We conclude that silent-site GC content correlates with gene expression efficiency in mammalian cells.

MeSH Terms
3' Untranslated Regions Base Composition/physiology Cytosine/analysis GC Rich Sequence Gene Expression Regulation Green Fluorescent Proteins/genetics,metabolism Guanine/analysis HSP70 Heat-Shock Proteins/genetics,metabolism HeLa Cells Humans Interleukin-2/genetics,metabolism Promoter Regions, Genetic RNA Processing, Post-Transcriptional RNA, Messenger/metabolism Transcription, Genetic
Chemicals
3' Untranslated Regions HSP70 Heat-Shock Proteins IL2 protein, human Interleukin-2 RNA, Messenger enhanced green fluorescent protein Green Fluorescent Proteins Guanine Cytosine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kudla Grzegorz
International Institute of Molecular and Cell Biology, Warsaw, Poland. gkudla@cgr.harvard.edu
Lipinski Leszek
Caffin Fanny
Helwak Aleksandra
Zylicz Maciej
References (72)
72 references, click to expand
  1. The mosaic genome of warm-blooded vertebrates.
    Science. 1985 May 24;228(4702):953-8 PMID: 4001930
  2. Diversity in G + C content at the third position of codons in vertebrate genes and its cause.
    Nucleic Acids Res. 1986 Aug 26;14(16):6345-55 PMID: 3748815
  3. Interleukin-2: inception, impact, and implications.
    Science. 1988 May 27;240(4856):1169-76 PMID: 3131876
  4. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences.
    Nature. 1988 Nov 24;336(6197):396-9 PMID: 3194021
  5. "Silent" sites in Drosophila genes are not neutral: evidence of selection among synonymous codons.
    Mol Biol Evol. 1988 Nov;5(6):704-16 PMID: 3146682
  6. An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels.
    J Virol. 1991 Nov;65(11):5806-12 PMID: 1717710
  7. Mammalian gene evolution: nucleotide sequence divergence between mouse and rat.
    J Mol Evol. 1993 Oct;37(4):441-56 PMID: 8308912
  8. Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region.
    Blood. 1995 May 1;85(9):2447-54 PMID: 7727775
  9. Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene.
    J Virol. 1995 Aug;69(8):5167-70 PMID: 7609089
  10. The evolution of isochores.
    Nat Rev Genet. 2001 Jul;2(7):549-55 PMID: 11433361
  11. Roles of RNA:DNA hybrid stability, RNA structure, and active site conformation in pausing by human RNA polymerase II.
    J Mol Biol. 2001 Aug 10;311(2):265-82 PMID: 11478860
  12. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.
    J Virol. 2001 Nov;75(22):10991-1001 PMID: 11602739
  13. Determinants of CpG islands: expression in early embryo and isochore structure.
    Genome Res. 2001 Nov;11(11):1854-60 PMID: 11691850
  14. Correlations between mRNA expression levels and GC contents of coding and untranslated regions of genes in rodents.
    J Mol Evol. 2002 Jan;54(1):35-41 PMID: 11734896
  15. A maximum likelihood method for analyzing pseudogene evolution: implications for silent site evolution in humans and rodents.
    Mol Biol Evol. 2002 Jan;19(1):110-7 PMID: 11752196
  16. Integrating mRNA processing with transcription.
    Cell. 2002 Feb 22;108(4):501-12 PMID: 11909521
  17. Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells.
    Nat Biotechnol. 1996 May;14(5):610-4 PMID: 9630952
  18. The intrinsic structure and stability of out-of-alternation base pairs in Z-DNA.
    Nucleic Acids Res. 1999 Jan 15;27(2):543-50 PMID: 9862978
  19. Expression pattern and, surprisingly, gene length shape codon usage in Caenorhabditis, Drosophila, and Arabidopsis.
    Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4482-7 PMID: 10200288
  20. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability.
    J Virol. 1999 Jun;73(6):4972-82 PMID: 10233959
  21. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1.
    J Virol. 1995 Sep;69(9):5607-20 PMID: 7637007
  22. c-fos mRNA instability determinants present within both the coding and the 3' non coding region link the degradation of this mRNA to its translation.
    Oncogene. 1995 Nov 16;11(10):2127-34 PMID: 7478533
  23. Identification of sequences in c-myc mRNA that regulate its steady-state levels.
    Mol Cell Biol. 1996 Jul;16(7):3511-22 PMID: 8668167
  24. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells.
    J Virol. 1996 Jul;70(7):4646-54 PMID: 8676491
  25. Codon usage limitation in the expression of HIV-1 envelope glycoprotein.
    Curr Biol. 1996 Mar 1;6(3):315-24 PMID: 8805248
  26. Comparative evolutionary rates of introns and exons in murine rodents.
    J Mol Evol. 1997 Aug;45(2):125-30 PMID: 9236271
  27. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells.
    Gene. 1997 Oct 15;199(1-2):293-301 PMID: 9358069
  28. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage.
    J Virol. 1998 Feb;72(2):1497-503 PMID: 9445053
  29. mRNA instability elements in the human papillomavirus type 16 L2 coding region.
    J Virol. 1998 Feb;72(2):1504-15 PMID: 9445054
  30. Codon usage tabulated from international DNA sequence databases: status for the year 2000.
    Nucleic Acids Res. 2000 Jan 1;28(1):292 PMID: 10592250
  31. Structure of a transcribing T7 RNA polymerase initiation complex.
    Science. 1999 Dec 17;286(5448):2305-9 PMID: 10600732
  32. Determinants of substitution rates in mammalian genes: expression pattern affects selection intensity but not mutation rate.
    Mol Biol Evol. 2000 Jan;17(1):68-74 PMID: 10666707
  33. mRNA stability in eukaryotes.
    Curr Opin Genet Dev. 2000 Apr;10(2):193-8 PMID: 10753781
  34. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.
    J Virol. 2000 May;74(10):4839-52 PMID: 10775623
  35. Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression.
    J Virol. 2000 Nov;74(22):10822-6 PMID: 11044131
  36. Evidence for purifying selection acting on silent sites in BRCA1.
    Trends Genet. 2001 Feb;17(2):62-5 PMID: 11173101
  37. The cap-to-tail guide to mRNA turnover.
    Nat Rev Mol Cell Biol. 2001 Apr;2(4):237-46 PMID: 11283721
  38. Synonymous codon bias is not caused by mutation bias in G+C-rich genes in humans.
    Mol Biol Evol. 2001 Jun;18(6):982-6 PMID: 11371586
  39. Evidence of selection on silent site base composition in mammals: potential implications for the evolution of isochores and junk DNA.
    Genetics. 1999 Jun;152(2):675-83 PMID: 10353909
  40. Isochores result from mutation not selection.
    Nature. 1999 Jul 1;400(6739):30-1 PMID: 10403245
  41. Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms.
    Biochem Biophys Res Commun. 1999 Aug 2;261(2):445-51 PMID: 10425204
  42. Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes.
    Nucleic Acids Res. 1999 Aug 1;27(15):3173-82 PMID: 10454615
  43. Relationship between gene expression and GC-content in mammals: statistical significance and biological relevance.
    Hum Mol Genet. 2005 Feb 1;14(3):421-7 PMID: 15590696
  44. In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.
    J Gene Med. 2005 Feb;7(2):189-97 PMID: 15515141
  45. Biased codon usage near intron-exon junctions: selection on splicing enhancers, splice-site recognition or something else?
    Trends Genet. 2005 May;21(5):256-9 PMID: 15851058
  46. Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution.
    Proc Natl Acad Sci U S A. 2005 May 3;102(18):6368-72 PMID: 15840711
  47. How sequence defines structure: a crystallographic map of DNA structure and conformation.
    Proc Natl Acad Sci U S A. 2005 May 17;102(20):7157-62 PMID: 15870206
  48. Hearing silence: non-neutral evolution at synonymous sites in mammals.
    Nat Rev Genet. 2006 Feb;7(2):98-108 PMID: 16418745
  49. No evidence for tissue-specific adaptation of synonymous codon usage in humans.
    Mol Biol Evol. 2006 Mar;23(3):523-9 PMID: 16280544
  50. Assay for intracellular calcium using a codon-optimized aequorin.
    Biotechniques. 2002 Oct;33(4):730, 732, 734 PMID: 12398176
  51. Evolution of synonymous codon usage in metazoans.
    Curr Opin Genet Dev. 2002 Dec;12(6):640-9 PMID: 12433576
  52. Initial sequencing and comparative analysis of the mouse genome.
    Nature. 2002 Dec 5;420(6915):520-62 PMID: 12466850
  53. DNA helix: the importance of being GC-rich.
    Nucleic Acids Res. 2003 Apr 1;31(7):1838-44 PMID: 12654999
  54. Selection on human genes as revealed by comparisons to chimpanzee cDNA.
    Genome Res. 2003 May;13(5):831-7 PMID: 12727903
  55. Timeline: Z-DNA: the long road to biological function.
    Nat Rev Genet. 2003 Jul;4(7):566-72 PMID: 12838348
  56. Isochores and tissue-specificity.
    Nucleic Acids Res. 2003 Sep 1;31(17):5212-20 PMID: 12930973
  57. The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes.
    Genome Res. 2003 Sep;13(9):1998-2004 PMID: 12915492
  58. A unification of mosaic structures in the human genome.
    Hum Mol Genet. 2003 Oct 1;12(19):2411-5 PMID: 12915446
  59. Cancer immunotherapy using cells modified with cytokine genes.
    Acta Biochim Pol. 2003;50(3):613-24 PMID: 14515144
  60. The signature of selection mediated by expression on human genes.
    Genome Res. 2003 Oct;13(10):2260-4 PMID: 12975314
  61. Mammalian mutation pressure, synonymous codon choice, and mRNA degradation.
    J Mol Evol. 2003 Dec;57(6):694-701 PMID: 14745538
  62. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression.
    Virology. 2004 Feb 20;319(2):163-75 PMID: 15015498
  63. Similar rates but different modes of sequence evolution in introns and at exonic silent sites in rodents: evidence for selectively driven codon usage.
    Mol Biol Evol. 2004 Jun;21(6):1014-23 PMID: 15014158
  64. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes.
    Nature. 2004 May 20;429(6989):268-74 PMID: 15152245
  65. A highly active synthetic mammalian retrotransposon.
    Nature. 2004 May 20;429(6989):314-8 PMID: 15152256
  66. Gene conversion and GC-content evolution in mammalian Hsp70.
    Mol Biol Evol. 2004 Jul;21(7):1438-44 PMID: 15084682
  67. Tissue-specific codon usage and the expression of human genes.
    Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12588-91 PMID: 15314228
  68. Gene-based vaccines and immunotherapeutics.
    Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14567-71 PMID: 15333750
  69. Evidence for codon bias selection at the pre-mRNA level in eukaryotes.
    Trends Genet. 2004 Nov;20(11):534-8 PMID: 15475111
  70. Codon selection in yeast.
    J Biol Chem. 1982 Mar 25;257(6):3026-31 PMID: 7037777
  71. Correlation between the abundance of yeast transfer RNAs and the occurrence of the respective codons in protein genes. Differences in synonymous codon choice patterns of yeast and Escherichia coli with reference to the abundance of isoaccepting transfer RNAs.
    J Mol Biol. 1982 Jul 15;158(4):573-97 PMID: 6750137
  72. Codon usage in bacteria: correlation with gene expressivity.
    Nucleic Acids Res. 1982 Nov 25;10(22):7055-74 PMID: 6760125
Article Info
Journal
PLoS biology
Abbr.
PLoS Biol
ISSN
1545-7885
Published
2006-06-00
Epub
2006-00-23
Pages
e180
Language
English
Region
United States
NLM ID
101183755
PMCID
PMC1463026
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com